Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

Chandrababu Naidu launched a vaccine, Biolumpivaxin, developed by Biovet, aimed at improving disease surveillance in livestock to protect them from lumpy skin disease (LSD), at the Livestock ...

The Infinix Note 50x 5G+ impresses with its sleek design, bypass charging, and value for money. Powered by the Dimensity 7300 ...

Down syndrome (DS) is the most prevalent genetic cause of Alzheimer’s disease (AD). Previous evidence suggests that increased dosage of the amyloid precursor protein (APP) gene plays a crucial role in ...

Sanofi and Regeneron should hear from the FDA in the autumn whether it will approve their blockbuster immunology drug Dupixent as a therapy for rare skin disease prurigo nodularis (PN).

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster ... a 90% or greater reduction in disease severity, compared to 10% of ...

Icotrokinra helped 66% of patients with scalp psoriasis and 77% of those with genital psoriasis achieve significantly clear skin compared to 11% and 21% success rate in patients on placebo ...

smooth skin in the morning! Gives your face such a beautiful glow. I also have sensitive skin and have had no issues with this product." "Mainly use this for my skincare routine, but as a black ...

Autoimmune pathology characterised by skin depigmentation, vitiligo is subject to many clichés. This dermatological disease is not psychosomatic, but the consequences it has on patients' lives ...

The House passed a major Republican bill dubbed "the Big Beautiful Bill'' by President Trump early this morning. According to USA Today, the bill passed the House 215-214, with all Democrats and ...

(Reuters) -Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily pill helped patients achieve clear or almost clear skin.